TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LAKININIMODA AND FAMPRIDINE

摘要

The invention relates to a method of treating a subject affected by multiple sclerosis or demonstrating a clinically isolated syndrome, comprising administering to the subject fampridine as an adjunct therapy or in combination with laquinimod. The invention also relates to the packaging of a medicinal product, including laquinimod and fampridine, for the treatment of a subject affected by multiple sclerosis or showing a clinically isolated syndrome. Further, the invention relates to fampridine for use as adjunctive therapy or in combination with laquinimod in the treatment of a subject affected by multiple sclerosis or demonstrating a clinically isolated syndrome. Further, the invention relates to a pharmaceutical composition comprising laquinimod and fampridine for use in the treatment of a subject affected by multiple sclerosis or demonstrating a clinically isolated syndrome. In addition, the invention relates to the use of laquinimod and fampridine in the preparation of a combination for the treatment of a subject affected by multiple sclerosis or showing a clinically isolated syndrome.